Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
The Department of Justice and mifepristone manufacturer Danco Laboratories have petitioned the Supreme Court to review a lower court’s decision that would limit use of
STOCKHOLM — Atrophic age-related macular degeneration control appeared better with pegcetacoplan (Syfovre) as compared with avacincaptad pegol (Izervay) in a propensity-matched cross-trial comparison. The comparison,